Austin, Texas, October 7th, 2026, FinanceWireVERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Oneness Biotech completed the SAD portion of its Phase 1 trial evaluating SNS851 as a potential treatment for ...

Session: Advances in Oncology Panel Presenter: Walter Klemp, Chairman and Chief Executive Officer of Moleculin Date/time: Wednesday, October 14, 2026, from 9:00 - 10:00 a.m. ET Location: NYY Room at ...

Austin, Texas, September 24th, 2026, FinanceWireVERAXA Biotech (NASDAQ: VRXA) is shifting its focus to advancing its ...

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Biotechnology Market - Therapeutic Innovations & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. Global Biotechnology ...

The global white biotechnology market is forecast to expand from USD 334.755 billion in 2025 to USD 541.097 billion by 2031, representing a compound annual growth rate of 8.33%. Market growth is being ...

The life sciences industry is experiencing transformative shifts driven by technological innovation and urgent global health needs. AAA Biotech, a leading provider of premium research reagents, is ...

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...

A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus on plants at the molecular level, paving the way for next-generation crop ...

Advances FDA-Aligned Methods To Reduce Animal Testing. VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on its strategy to implement U.

(MENAFN- GlobeNewsWire - Nasdaq) Demand for low-carbon biofuels, bioplastics, chemicals and enzymes is rising, fueled by policy and biotech advances. Asia-Pacific offers strong scaling opportunities.